Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study-Reference-Cited by-同舟云学术

Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study

Published:2017-04 Issue:4 Volume:5 Page:261-270
ISSN:2213-8587
Container-title:The Lancet Diabetes & Endocrinology
language:en
Short-container-title:The Lancet Diabetes & Endocrinology

Author:

Bally Lia,Thabit Hood,Kojzar Harald,Mader Julia K,Qerimi-Hyseni Jehona,Hartnell Sara,Tauschmann Martin,Allen Janet M,Wilinska Malgorzata E,Pieber Thomas R,Evans Mark L,Hovorka Roman

Funder

Swiss National Science Foundation

JDRF

National Institute for Health Research Cambridge Biomedical Research Centre

Wellcome Strategic Award

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference31 articles.

1. Approaches to glycemic treatment;Diabetes Care,2016

2. Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trial;Pedersen-Bjergaard;Lancet Diabetes Endocrinol,2014